Amalgamated Bank Mi Nk Therapeutics, Inc. Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.25 - $3.25 $368 - $958
-295 Closed
0 $0
Q1 2022

Jun 30, 2022
BUY
$2.2 - $4.75 $649 - $1,401
295 New
295 $1,000

Others Institutions Holding INKT

# of Institutions
4
Shares Held
106K
Call Options Held
0
Put Options Held
0
View Full List

About MiNK Therapeutics, Inc.

INKT Quotes by TradingView
  • Ticker INKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,775,100
  • Market Cap $245M
  • Description
  • MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...
More about INKT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email